Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan

Journal Of Gastroenterology

by Tetsuya Takikawa, Yoichi Kakuta, Kazuhiro Kikuta, Serina Haruyama, Ami Kawamoto, Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroshi Nagai, Takanori Sano, Mikihiro Fujiya, Takuto Saiki, Masanao Nakamura, Atsushi Nishida, Sakiko Hiraoka, Takayuki Matsumoto, Katsuya Endo, Kazuyuki Narimatsu, Shojiro Yamamoto, Takashi Kagaya, Shin-ichiro Hagiwara, Noritaka Takatsu, Hiroshi Nakase, Kazuichi Okazaki, Yoki Furuta, Tetsu Kinjo, Soichiro Ishihara, Hirotake Sakuraba, Takashi Tashiro, Makoto Naganuma, Fukunori Kinjo, Tomohisa Takagi, Tadakazu Hisamatsu, Mitsuhiro Kawano, Atsushi Masamune
June 29, 2026

The Medicine Maker

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

May 12, 2026
7 min

Frontiers In Medicine

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis

by Lidan Zhang, Xiaogang Hao, Yidan Cui, Wenjian Yan, Kun Shang, Xin Zhang
June 11, 2026

Frontiers In Immunology

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease

by Haitao Chu, Xin Song, Chang Liu, Tianjiao Ma, Wanlin Cui
June 9, 2026

Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan

Original Source(s)

Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan

Related Content

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease